427 related articles for article (PubMed ID: 29400110)
1. Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway.
Zhang X; Ji R; Sun H; Peng J; Ma X; Wang C; Fu Y; Bao L; Jin Y
Free Radic Res; 2018 Feb; 52(2):198-211. PubMed ID: 29400110
[TBL] [Abstract][Full Text] [Related]
2. Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats.
Fan H; Ma X; Lin P; Kang Q; Zhao Z; Wang L; Sun D; Cheng J; Li Y
Med Sci Monit; 2017 Nov; 23():5599-5612. PubMed ID: 29172017
[TBL] [Abstract][Full Text] [Related]
3. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation.
Feng X; Yu W; Li X; Zhou F; Zhang W; Shen Q; Li J; Zhang C; Shen P
Biochem Pharmacol; 2017 Jul; 136():136-149. PubMed ID: 28414138
[TBL] [Abstract][Full Text] [Related]
4. Scutellarin attenuates hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and oxidative stress through regulating Keap1/Nrf2/ARE signaling.
Wu H; Jia L
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31654068
[TBL] [Abstract][Full Text] [Related]
5. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
6. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
7. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
[TBL] [Abstract][Full Text] [Related]
8. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
[TBL] [Abstract][Full Text] [Related]
9. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.
Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X
Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437
[TBL] [Abstract][Full Text] [Related]
10. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet.
Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
12. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
13. Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease.
Jiang Y; Chen D; Gong Q; Xu Q; Pan D; Lu F; Tang Q
Lipids Health Dis; 2021 Apr; 20(1):40. PubMed ID: 33902605
[TBL] [Abstract][Full Text] [Related]
14. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway.
Qu LL; Yu B; Li Z; Jiang WX; Jiang JD; Kong WJ
Phytother Res; 2016 Mar; 30(3):402-11. PubMed ID: 26634892
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
[TBL] [Abstract][Full Text] [Related]
16. S-Propargyl-cysteine Exerts a Novel Protective Effect on Methionine and Choline Deficient Diet-Induced Fatty Liver via Akt/Nrf2/HO-1 Pathway.
Li W; Ma F; Zhang L; Huang Y; Li X; Zhang A; Hou C; Zhu Y; Zhu Y
Oxid Med Cell Longev; 2016; 2016():4690857. PubMed ID: 27313828
[TBL] [Abstract][Full Text] [Related]
17. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
Im AR; Kim YH; Lee HW; Song KH
J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
[TBL] [Abstract][Full Text] [Related]
18. Plant sterol ester of α-linolenic acid ameliorates high-fat diet-induced nonalcoholic fatty liver disease in mice: association with regulating mitochondrial dysfunction and oxidative stress via activating AMPK signaling.
Han H; Li X; Guo Y; Zheng M; Xue T; Wang L
Food Funct; 2021 Mar; 12(5):2171-2188. PubMed ID: 33566044
[TBL] [Abstract][Full Text] [Related]
19. Silent information regulator 1 ameliorates oxidative stress injury via PGC-1α/PPARγ-Nrf2 pathway after ischemic stroke in rat.
Zhou Y; Peng L; Li Y; Zhao Y
Brain Res Bull; 2022 Jan; 178():37-48. PubMed ID: 34774993
[TBL] [Abstract][Full Text] [Related]
20. RNase MCPIP1 regulates hepatic peroxisome proliferator-activated receptor gamma via TXNIP/PGC-1alpha pathway.
Pydyn N; Kadluczka J; Kus E; Pospiech E; Losko M; Fu M; Jura J; Kotlinowski J
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1458-1471. PubMed ID: 31185306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
